Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis

Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset. Our aim is to investigate the diagnostic value of anti-CarP antibody in Egyptian RA patients. Methods: This cross-sectional study included 96 RA p...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashraf H Mohamed, Asmaa Enein, Noha Abdelsalam, Mona Balata, Sameh Abdellatif, Ehsan Rizk, Ahmed Fathy
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=37;epage=41;aulast=Mohamed
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561317142429696
author Ashraf H Mohamed
Asmaa Enein
Noha Abdelsalam
Mona Balata
Sameh Abdellatif
Ehsan Rizk
Ahmed Fathy
author_facet Ashraf H Mohamed
Asmaa Enein
Noha Abdelsalam
Mona Balata
Sameh Abdellatif
Ehsan Rizk
Ahmed Fathy
author_sort Ashraf H Mohamed
collection DOAJ
description Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset. Our aim is to investigate the diagnostic value of anti-CarP antibody in Egyptian RA patients. Methods: This cross-sectional study included 96 RA patients (56 patients with early disease and 40 patients with established disease) and 60 healthy controls. Demographic and clinical data, smoking status, and disease activity score were recorded. Laboratory tests included erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, anti-citrullinated protein antibodies, and anti-CarP antibody. Results: Anti-CarP antibody levels in RA patients were significantly higher than in controls (8.80 ± 5.95 vs. 2.19 ± 1.01, P < 0.0001). Out of 96 RA patients; 74 (77.1%) were positive for anti -CarP anti body including 47patients with early RA while only 5 subjects (8.3%) in control group were positive. Receiver-operating characteristic curve study for diagnostic efficacy of anti-CarP antibody in early RA diagnosis demonstrated a significant area under the curve, 0.950 (95% confidence interval, 0.912–0.987, P < 0.0001) and yielded a sensitivity of 85.4%, a specificity of 93.3%, a positive predictive value of 0.90, and a negative predictive value of 0.86. Conclusion: Anti-CarP antibody is a useful biomarker for early RA diagnosis.
format Article
id doaj-art-273026470fe544d6b08235a5de16fe75
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-273026470fe544d6b08235a5de16fe752025-01-03T01:45:19ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012019-01-01141374110.4103/injr.injr_110_18Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritisAshraf H MohamedAsmaa EneinNoha AbdelsalamMona BalataSameh AbdellatifEhsan RizkAhmed FathyBackground: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset. Our aim is to investigate the diagnostic value of anti-CarP antibody in Egyptian RA patients. Methods: This cross-sectional study included 96 RA patients (56 patients with early disease and 40 patients with established disease) and 60 healthy controls. Demographic and clinical data, smoking status, and disease activity score were recorded. Laboratory tests included erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, anti-citrullinated protein antibodies, and anti-CarP antibody. Results: Anti-CarP antibody levels in RA patients were significantly higher than in controls (8.80 ± 5.95 vs. 2.19 ± 1.01, P < 0.0001). Out of 96 RA patients; 74 (77.1%) were positive for anti -CarP anti body including 47patients with early RA while only 5 subjects (8.3%) in control group were positive. Receiver-operating characteristic curve study for diagnostic efficacy of anti-CarP antibody in early RA diagnosis demonstrated a significant area under the curve, 0.950 (95% confidence interval, 0.912–0.987, P < 0.0001) and yielded a sensitivity of 85.4%, a specificity of 93.3%, a positive predictive value of 0.90, and a negative predictive value of 0.86. Conclusion: Anti-CarP antibody is a useful biomarker for early RA diagnosis.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=37;epage=41;aulast=MohamedAnti-carbamylated protein antibodydiagnosisrheumatoid arthritis
spellingShingle Ashraf H Mohamed
Asmaa Enein
Noha Abdelsalam
Mona Balata
Sameh Abdellatif
Ehsan Rizk
Ahmed Fathy
Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
Indian Journal of Rheumatology
Anti-carbamylated protein antibody
diagnosis
rheumatoid arthritis
title Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
title_full Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
title_fullStr Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
title_full_unstemmed Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
title_short Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
title_sort utility of anti carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
topic Anti-carbamylated protein antibody
diagnosis
rheumatoid arthritis
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=37;epage=41;aulast=Mohamed
work_keys_str_mv AT ashrafhmohamed utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT asmaaenein utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT nohaabdelsalam utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT monabalata utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT samehabdellatif utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT ehsanrizk utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis
AT ahmedfathy utilityofanticarbamylatedproteinantibodiesinthediagnosisofearlyrheumatoidarthritis